Market Capitalization

RedHill Biopharma's new financing provides crucial cash, but the real story is in the warrants and the hunt for a strategic acquisition. A deep dive.

A massive conditional loan from the Pentagon's investment arm aims to transform a Utah uranium mill into a cornerstone of America's critical minerals strategy.

A Taipei delegation at BIO 2026 signals Taiwan's strategic pivot from manufacturing to R&D, seeking global partners for its late-stage drugs and platforms.

With a new 77.6M tonne estimate, NVRO Metals is not just building a mine but a tech-driven hub poised to reshape Australia's critical minerals supply chain.

A DoW contract for in-orbit refueling thrusts Quantum Space into the spotlight, promising to redefine space warfare and ignite the orbital logistics economy.

With a fresh $260M, Dream is building AI for nations to own. But as governments rush for digital autonomy, are we creating a new digital iron curtain?

Bitget's listing of Bluwhale AI isn't just another token. It's a test case for AI-driven credit in Web3 and a key move in the exchange's ambitious strategy.

A new report projects the wellness market will hit $12.9T by 2031. This isn't just about yoga mats; it's a tech-fueled, Asia-led economic realignment.

MotoGP's massive debt repricing reduces costs by millions, showcasing Liberty Media's proven strategy to optimize sports assets and fuel future performance.

Beyond a trade show, SIAL Guangzhou 2026 is China's strategic bid to become Asia's food larder, leveraging its manufacturing might to redefine supply chains.

CONMED appoints John Gallagher, a seasoned MedTech CFO, to navigate market headwinds and drive a new chapter of financial performance and shareholder value.

With a $110M boost, Nyxoah is bringing its innovative, battery-free sleep apnea device to the US. Is this the disruption patients have been waiting for?

A look inside Mingteng International's complex financing deal and its push to fund its role in the booming, competitive world of new energy vehicle parts.

A new $50.6M supportive housing project in Chilliwack opens its doors, but behind the celebration lies a story of massive costs and simmering local frustration.

Sol de Janeiro and the Washington Spirit's new deal is more than a sponsorship. It’s a blueprint for a future where brand, athlete, and fan share an identity.

AB Science has secured a US patent until 2042 for masitinib, a targeted therapy for advanced prostate cancer, offering new hope where few options exist.

REPAY's acquisition of KUBRA, fueled by a massive $500M loan from Silver Point, creates a bill payment giant and signals private credit's growing M&A muscle.

With a $300M+ war chest, Adam Goodman's 'tradigital' studio aims to merge YouTube virality with Hollywood's franchise-building machine.

With identity now the top attack surface, Radiant Logic hires industry veteran Eric Neal to lead its charge against the complex 'Three Identity Problem'.

Sharon AI's massive financing reveals a deeper story: a global race to build the physical backbone for AI, fueled by visionary bets and cautious capital.